NCT03434444View on ClinicalTrials.gov

In Vitro Optimization of Oxytocin-induced Myometrial Contractility by Propranolol

NACompletedINTERVENTIONAL
Enrollment

57

Participants

Timeline

Start Date

September 8, 2017

Primary Completion Date

August 19, 2022

Study Completion Date

August 20, 2022

Conditions
Postpartum Hemorrhage
Interventions
DRUG

Oxytocin

Oxytocin in solution, ranging from 10 -12M to 10 -5M

DRUG

Propranolol

Propranolol in solution, 10-6M

Trial Locations (1)

M5G1X5

Mount Sinai Hospital, Toronto

All Listed Sponsors
lead

Samuel Lunenfeld Research Institute, Mount Sinai Hospital

OTHER

NCT03434444 - In Vitro Optimization of Oxytocin-induced Myometrial Contractility by Propranolol | Biotech Hunter | Biotech Hunter